Bitcoin’s Sell in May Phase & New ETFs: Key Insightsby John Darbie 25.06.2024"Analyst Mark Wong discusses Bitcoin's potential 'Sell in May' phase, market trends, ETF outflows, and future prospects amid market volatility."
Ethereum Eyes $5,000? CME Interest Expands Amid ETF Optimismby John Darbie 25.06.2024"Ethereum eyes $5,000 as CME futures interest surges, analysts optimistic despite current bearish trend and resistance at $3,700."
Micron Stock Target Raised to $175 by Citi, Bairdby Mark Eisenberg 24.06.2024"Micron stock rises as Citi, Baird raise price targets ahead of Q4 results, citing strong DRAM prices and AI memory ...
Dogecoin Trading Volume Surges 186% Despite Bearish Trendby John Darbie 24.06.2024Dogecoin's trading volume surged 186%, hitting $1.37B. Despite a 25.48% monthly drop, high interest suggests potential price recovery.
Kroger Reports Modest Growth and Strategic Investmentsby Mark Eisenberg 24.06.2024Kroger's Q1 2024 shows modest growth in same-store, online, and delivery sales; optimistic amid economic challenges and Albertsons merger plans.
Top 27 Altcoins: Crypto Banter Founder Reveals Low-Risk Picksby John Darbie 24.06.2024Discover Ran Neuner's top 27 Ethereum-based low-risk, high-return altcoins poised for significant growth in the next bull run. Learn more ...
UBS Neutral on EM Stocks; Favors Tech in China, S. Koreaby Mark Eisenberg 24.06.2024UBS neutral on EM stocks due to political risks but favors AI-related tech stocks in Taiwan and South Korea, and ...
Why Monitoring Ethereum Is Crucial Amid Market Shiftsby John Darbie 24.06.2024Explore why Ethereum's resilience amid Bitcoin's downturn could signal a pivotal rise for altcoins, backed by key analyst insights and ...
Ethereum Spot ETFs: Could They Fuel a $4K ETH Surge?by John Darbie 23.06.2024Will Ethereum hit $4K post-ETF launch? Analysts are divided, citing mixed market demand and comparisons to Bitcoin ETFs.
Numinus Wellness Acquires MedBright AI, Rebrands as Numinus Intelligenceby Lilu Anderson 23.06.2024"Numinus Wellness acquires MedBright AI, merging AI with psychedelics for advanced mental health care and expanded services in the U.S."